K-PAX and Stanford University partner for study to treat of chronic fatigue syndrome

US-based K-PAX Pharmaceuticals is collaborating with Stanford University and several other research institutions to carry out a Phase II double-blind, placebo-controlled Synergy study for the treatment of chronic fatigue syndrome (CFS).
Source: Drug Development Technology - Category: Pharmaceuticals Source Type: news